Collegium Pharmaceutical Inc reports results for the quarter ended in December - Earnings Summary

Collegium Pharmaceutical

23/02/2023 22:02

* Collegium Pharmaceutical Inc  COLL.OQ  reported a
quarterly
adjusted loss of 21 cents​​ per share for the quarter ended in
December. The mean expectation of six analysts for the quarter
was for a loss of 14 cents per share.
    * Revenue rose 373.7% to $129.62 million from a year ago;
analysts
expected $125.19 million. 
    * Collegium Pharmaceutical Inc's reported EPS for the
quarter was
a loss of 21 cents​.
    * The mean earnings estimate of analysts had risen by
about 14.7%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Collegium Pharmaceutical Inc shares had risen by 13.8%
this
quarter.
    * The company reported a quarterly loss of $7.2 million.
    * Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is $36.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
23 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.14          -0.21          Missed
 Sep. 30 2022      -0.13          0.01           Beat
 Jun. 30 2022      1.42           0.32           Missed
 Mar. 31 2022      0.90           0.44           Missed